Sector: N/A | Industry: N/A |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 222 Robert Rose Dr MURFREESBORO TN 37129 |
Tel: | N/A |
Website: | https://www.nhireit.com |
IR: | See website |
Key People | ||
D. Eric Mendelsohn President, Chief Executive Officer, Director | John L. Spaid Chief Financial Officer, Executive Vice President, Treasurer | Kevin Carlton Pascoe Executive Vice President, Chief Investment Officer |
David L. Travis Senior Vice President, Chief Accounting Officer | Kristin S. Gaines Senior Vice President, Chief Transaction Officer |
Business Overview |
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units. |
Financial Overview |
For the fiscal year ended 31 December 2023, National Health Investors Inc revenues increased 15% to $319.8M. Net income applicable to common stockholders increased from $66.4M to $135.6M. Revenues reflect Real Estate Investments segment increase of 12% to $270.7M, NAREIT FFO - Per Share - Basic - Total increase of 24% to $4.39, NAREIT FFO - Per Share - Diluted - Total increase of 24% to $4.39. |
Employees: | 26 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,784M as of Dec 31, 2023 |
Annual revenue (TTM): | $319.84M as of Dec 31, 2023 |
EBITDA (TTM): | $248.47M as of Dec 31, 2023 |
Net annual income (TTM): | $135.60M as of Dec 31, 2023 |
Free cash flow (TTM): | -$13.61M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,113M as of Dec 31, 2023 |
Shares outstanding: | 43,424,841 as of Mar 28, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |